Page last updated: 2024-09-03

dx 9065a and fibrinogen

dx 9065a has been researched along with fibrinogen in 2 studies

Compound Research Comparison

Studies
(dx 9065a)
Trials
(dx 9065a)
Recent Studies (post-2010)
(dx 9065a)
Studies
(fibrinogen)
Trials
(fibrinogen)
Recent Studies (post-2010) (fibrinogen)
927834,4771,7077,083

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoshima, K; Asakura, H; Ikeda, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M1
Hara, T; Ishihara, H; Iwamoto, M; Tanabe, K; Yokoyama, A1

Other Studies

2 other study(ies) available for dx 9065a and fibrinogen

ArticleYear
Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:3

    Topics: Administration, Oral; Animals; Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation, Preclinical; Endotoxins; Factor Xa Inhibitors; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney Glomerulus; Male; Naphthalenes; Partial Thromboplastin Time; Platelet Count; Propionates; Prothrombin Time; Rats; Rats, Wistar; Thromboplastin

1994
DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
    Thrombosis and haemostasis, 1995, Volume: 74, Issue:2

    Topics: Animals; Anticoagulants; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Coagulation; Disseminated Intravascular Coagulation; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Male; Naphthalenes; Platelet Count; Propionates; Rats; Rats, Wistar; Thromboplastin

1995